Clinical observation of modified Danzhi Xiaoyao powder in treating post-stroke depression
Juan Yang
Abstract
Juan Yang
Abstract
[Objective]To observe the curative effect of modified Danzhi Xiaoyao powder in treating patients with post-stroke depression. [Methods] The patients with post-stroke depression were randomly divided into three groups: modified Danzhi Xiaoyao powder group, fluoxetine and the combined group. All patients were treated with routine medicine also. The neurological and cognitive function determined with HAMD scale, MMSE scale , SSS scale and Barthel index (BI) before the treatment and at 4 and 12 weeks after treatment was evaluated. [Results] The AMD score and SSS score was significantly decreased (P0.01) while MMSE score and BI score was significantly increased (P0.05) after treatment of three groups. The decrease of HAMD score and increase of BI score in the combined group was more significant than those in the other two groups respectively ( P0.05). [Conclusion] Modified Danzhi Xiaoyao powder is effective in treating patients with post-stroke depression and shows synergism with fluoxetine.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective]To observe the curative effect of modified Danzhi Xiaoyao powder in treating patients with post-stroke depression. [Methods] The patients with post-stroke depression were randomly divided into three groups: modified Danzhi Xiaoyao powder group, fluoxetine and the combined group. All patients were treated with routine medicine also. The neurological and cognitive function determined with HAMD scale, MMSE scale , SSS scale and Barthel index (BI) before the treatment and at 4 and 12 weeks after treatment was evaluated. [Results] The AMD score and SSS score was significantly decreased (P0.01) while MMSE score and BI score was significantly increased (P0.05) after treatment of three groups. The decrease of HAMD score and increase of BI score in the combined group was more significant than those in the other two groups respectively ( P0.05). [Conclusion] Modified Danzhi Xiaoyao powder is effective in treating patients with post-stroke depression and shows synergism with fluoxetine.
Key concepts: Hamd, Medicine, SSS*, Post-stroke depression, Depression (economics), Internal medicine, Hamilton depression scale, Stroke (engine)